Answers are grounded in this paper and cite their sources.
Key Points Fc-engineered CD19 antibody cures MRD in ∼50% of mice xenografted with ALL cells and is highly synergistic in combination with chemotherapy. Macrophages are important effector cells for this antibody in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Schewe et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: